Irene Becklund sold $371k of HIMS
PAO at Hims & Hers Health, Inc.. 12,063 shares at an average of $30.72, traded Jun 16, 2026, filed Jun 17, 2026.
Score components
- +15RoleOfficer
- +15Trade size$371k at market
- +20Share of holdings soldSold 64% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001773751-26-000128, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | MOption exercise Class A Common Stock10b5-1 | +15,971 | - | - | 24,723 | Jun 17, 2026 |
| Jun 15, 2026 | FTax withholding Class A Common Stock10b5-1 | -5,870 | $30.17 | $177k | 18,853 | Jun 17, 2026 |
| Jun 16, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -7,573 | $30.25 | $229k | 11,280 | Jun 17, 2026 |
| Jun 17, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -4,490 | $31.50 | $141k | 6,790 | Jun 17, 2026 |
| Jun 15, 2026 | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,291 | $0.00 | $0 | 0 | Jun 17, 2026 |
| Jun 15, 2026 | MOption exercise Restricted Stock Unitderivative10b5-1 | -4,065 | $0.00 | $0 | 12,199 | Jun 17, 2026 |
| Jun 15, 2026 | MOption exercise Restricted Stock Unitderivative10b5-1 | -4,344 | $0.00 | $0 | 30,415 | Jun 17, 2026 |
| Jun 15, 2026 | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,392 | $0.00 | $0 | 15,322 | Jun 17, 2026 |
| Jun 15, 2026 | MOption exercise Restricted Stock Unitderivative10b5-1 | -3,879 | $0.00 | $0 | 58,197 | Jun 17, 2026 |
Related signals
Other insiders at Hims & Hers Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $101k 3,461 shares | -1% | |
| 17Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $59k 2,000 shares | -1% | |
| 30Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $877k 29,277 shares | -11% | |
| 32Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $355k 12,313 shares | -5% | |
| 21Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $174k 6,236 shares | -2% | |
| 31Weak | Hims & Hers Health, Inc. | Michael Chi Chief Operating Officer | $398k 14,027 shares | -3% | |
| 23Weak | Hims & Hers Health, Inc. | Mohamed Elshenawy CTO | $226k 7,954 shares | -4% | |
| 20Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $98k 3,458 shares | -1% | |
| 37Weak | Hims & Hers Health, Inc. | Deborah M. Autor Chief Policy Officer | $467k 16,773 shares | -26% | |
| 31Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $692k 25,111 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.